Deep Brain Stimulation Devices – Global Market Size, Share & Trends Analysis & Forecast to 2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Deep
Brain Stimulation Devices Market Size, Share & Trends Analysis Report By
Application (Pain Management, Epilepsy, Essential Tremor, OCD,
Depression, Dystonia, Parkinson’s), By Region, And Segment Forecasts,
2018 – 2025”
report has been added to ResearchAndMarkets.com’s
offering.

The global deep brain stimulation devices market size is expected to
reach USD 2.1 billion by 2025, progressing at a CAGR of over 11.9%
during the forecast period.

Growing prevalence of Parkinson’s disease coupled with surging demand
for cost-efficient surgical procedures, minimally invasive in nature, is
providing a fillip to the market.

A significant rise in the usage of deep brain stimulators by
neurologists in the treatment of various neurological diseases is
supplementing the growth of the market. These diseases include
Parkinson’s disease, obsessive-compulsive disorder, essential tremors,
and dystonia.

Pending product approvals from regulatory authorities such as the U.S.
FDA for the adoption of DBS in the treatment regime of refractory
epilepsy is also estimated to offer significant growth opportunities to
the market in the coming years.

Moreover, advent of technologically advanced concepts in DBS systems
such as fractionation of electric current and selective current
steering, which induces positive patient outcomes, is further projected
to fuel market growth prospects.

Key Findings

  • Parkinson’s disease accounted for the leading share in the market in
    2016 owing to benefits offered by DBS such as improvised motor
    symptoms for longer time period, fewer side effects, and ability to
    track momentary fluctuations.
  • Increasing number of drug-resistant cases in treatment of Parkinson’s
    disease is also a major factor escalating the growth of the market.
  • Obsessive-compulsive disorder held the second largest share in terms
    of revenue as a result of failure of serotonin reuptake inhibitors
    (SSRi) and positive patient outcomes associated with DBS.

Companies Featured

  • Medtronic PLC
  • Boston Scientific
  • St. Jude Medical Inc.
  • Aleva Neurotherapeutics S.A.

Topics Covered

Chapter 1. Executive Summary

Chapter 2. Deep Brain Stimulators Industry Outlook

Chapter 3. Deep Brain Stimulators Application Outlook

Chapter 4. Deep Brain Stimulators Regional Outlook

Chapter 5. Competitive Landscape

Chapter 6. Methodology and Scope

For more information about this report visit https://www.researchandmarkets.com/research/lr6qfn/deep_brain?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Neurology
Devices

leverton

I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.coom for scheduling information.